PreprintCited by 2,225Neuroinflammation and Neurodegeneration MechanismsSingle-cell and spatial transcriptomicsMultiple Sclerosis Research Studies

The DOI matches its Crossref record, with a small difference in title or year; 84 of the 84 references it cites were found in a registry or an index; none of the 32 sources its claims cite is checked for support yet.

Complex cell-state changes revealed by single cell RNA sequencing of 76,149 microglia throughout the mouse lifespan and in the injured brain

Open access

Abstract

Microglia, the resident immune cells of the brain, rapidly change states in response to their environment, but we lack molecular and functional signatures of different microglial populations. In this study, we analyzed the RNA expression patterns of more than 76,000 individual microglia during development, old age and after brain injury. Analysis uncovered at least nine transcriptionally distinct microglial states, which expressed unique sets of genes and were localized in the brain using specific markers. The greatest microglial heterogeneity was found at young ages; however, several states - including chemokine-enriched inflammatory microglia - persisted throughout the lifespan or increased in the aged brain. Multiple reactive microglial subtypes were also found following demyelinating injury in mice, at least one of which was also found in human MS lesions. These unique microglia signatures can be used to better understand microglia function and to identify and manipulate specific subpopulations in health and disease.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Single-cell RNA sequencing of 76,149 mouse microglia across development, aging, and demyelinating injury identifies at least nine transcriptionally distinct microglial states, with the greatest diversity early in development and state shifts in aging and injury. The study defines state-specific markers, validates several populations by in situ hybridization, and finds a Ccl4+ microglial subset in mouse lesions and human multiple sclerosis lesions.

Key findings

  • Across all ages and conditions, clustering revealed nine unique microglial states, with cluster sizes ranging from 0.2% to 24% of all microglia; canonical microglial genes were not uniformly expressed, as only C1qa, Fcrls, and Trem2 were expressed in all clusters.
  • Microglial diversity was greatest at E14.5 and P5 and lower at P30 and P100; aging and injury redistributed states, including increases in Clusters 8 and 9. In aged P540 versus P100 mice, there were 2–4 times more microglia in aging-enriched Clusters OA2 and OA3, with OA2 expressing inflammatory genes such as Ccl4, Ccl3, and Il1b and OA3 expressing interferon-response genes including Ifitm3, Rtp4, and Oasl2.
  • In LPC-induced demyelination at 7 days post-lesion, injury-responsive Cluster IR2 was almost entirely composed of lesion microglia and subclustered into IR2.1–2.4; IR2.2 upregulated Cxcl10, and IR2.2/IR2.3 upregulated Ccl4. IRM shared a 12-gene core signature with disease-associated microglia (DAM), including Spp1, Lpl, and Apoe, but also had unique interferon-response genes.
  • Sex had almost no effect on microglial diversity or cluster proportions across E14.5, P4/P5, and P100; the only observed difference was female enrichment of the small Cluster Sx6 (~0.5% of microglia, observed only at P4/P5, enriched for Cd74, Ccl24, and Arg1). In human MS lesions, approximately 30% of microglia in the lesion were Ccl4+.

Methods

  • Microglia were FACS-purified from C57BL/6J mice at E14.5, P4/P5, P30, P100, and P540, plus adult P100 mice after focal LPC-induced demyelination at 7 days post-lesion; at least three to four biological replicates per age were collected, totaling 76,149 sequenced microglia from 41 animals.
  • Cells were processed with a droplet-based RNA-seq approach (10× Genomics Chromium), sequenced to ~40,000–60,000 reads/cell, and analyzed using an independent component analysis (ICA)-based clustering pipeline, including subclustering and canonical correlation analysis (CCA) for comparison with published DAM data.
  • Findings were validated with single-molecule fluorescent in situ hybridization (smFISH), chromogenic in situ hybridization, and immunohistochemistry in mouse tissue, and with human MS tissue from the UK MS Tissue Bank; statistical analyses included ANOVA with Tukey’s post hoc tests, t-tests, and gene-marker thresholds of >1.5 fold change and P < 1E-4 with Benjamini–Hochberg correction.

Limitations

  • Stated: further analysis is needed to establish whether the identified states are transient or represent terminal differentiation; lineage tracing is needed to determine the origin of Cluster 6 microglia and whether they give rise to mature microglia; manipulation of aged inflammatory microglia is needed to test whether they contribute to age-related brain inflammation; the small female-enriched Cluster Sx6 requires further validation; and whether other mouse lesion-enriched genes translate to human microglia needs confirmation.
  • Evident: the main dataset is mouse-based, and the injury analysis focuses on a single model (LPC-induced demyelination) at one time point (7 days post-lesion); human MS validation was limited to five control/patient samples and centered on Ccl4/Tmem119 staining.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1101/406140

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 32 cited sources checked · 0 supported · 0 flagged

Show all 131 claims

  • It may state two separate claims as one. 65
  • Probably not a substantial claim. 31
86 of 86
  • The paper relies on this without support.

    Microglia rapidly change states in response to their environment.

    “Microglia, the resident immune cells of the brain, rapidly change states in response to their environment”
  • The paper relies on this without support.

    There is a lack of molecular and functional signatures of different microglial populations.

    “but we lack molecular and functional signatures of different microglial populations”
  • The paper relies on this without support.

    Microglia have historically been characterized as resting, M1, or M2 based on simple in vitro stimulation methods.

    “microglia have historically been characterized as ‘resting’, ‘M1’ (proinflammatory), or ‘M2’ (anti-inflammatory) - based on simple in vitro stimulation methods.”
  • The paper relies on this without support.

    It is still unclear when microglia diverge from brain border neighbors and how quickly they differentiate.

    “However, it is still unclear when microglia diverge from their brain border neighbors and how quickly they differentiate.”
  • The paper relies on this without support.

    It is not until microglia infiltrate the brain parenchyma and are exposed to brain-derived signals that they achieve their unique identity.

    “It is not until microglia infiltrate the brain parenchyma and are exposed to brain-derived signals that they achieve their unique identity.”
  • The paper relies on this without support.

    The extent of the microglial response to aging has not been comprehensively studied, and it remains unclear how, where, and to what extent microglia change with normal aging.

    “However, the extent of the microglial response to aging has not been comprehensively studied, and it remains unclear how, where (in the brain), and to what extent microglia change with normal aging.”
  • The paper relies on this without support.

    It is unclear whether microglia tailor their responses to specific injury types or whether distinct microglial populations exist in pathological tissue.

    “However, it is still unclear whether or how microglia tailor their response to specific injury types or whether distinct populations of microglia exist in pathological tissue, as we lack both the markers and tools to identify and characterize different activation states, should they exist.”
  • The paper relies on this without support.

    Microglia respond robustly and rapidly to demyelination in the LPC model.

    “third, microglia respond robustly and rapidly to demyelination in this model”
  • The paper relies on this without support.

    Microglial activation is largely confined to the lesion where demyelination occurred.

    “microglial activation is largely confined to the lesion where the demyelination has occurred.”
  • The paper relies on this without support.

    At 7 days post-lesion, microglia are highly responsive and the lesion is transitioning from myelin debris cleanup to initial remyelination.

    “We focused our analysis on 7 days post-lesion (7 dpl), a time point at which microglia are highly responsive and the lesion is undergoing a transition from myelin debris cleanup to the initial phases of remyelination (Fig 6a).”
  • The paper relies on this without support.

    Demyelinated lesions contain a high density of activated microglia, generally in the core, where they can remove myelin debris and release factors into the lesion microenvironment.

    “Demyelinated lesions contain a high density of activated microglia, generally in the core, where they can remove myelin debris and release factors into the lesion microenvironment.”
  • The paper relies on this without support.

    In MS, infiltrating immune cells specifically target myelin and cause white matter lesions.

    “In MS, infiltrating immune cells specifically target myelin and cause white matter lesions.”
  • The paper relies on this without support.

    Microglia migrate, grow, and proliferate in response to injury.

    “Because microglia migrate, grow, and proliferate in response to injury”
13 of 13

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 83 references

Cited by

Sorted by citations

Items 801–900 of 1,016

Metadata

Authors
Hammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., Macosko, E., Franklin, R. J. M., Piao, X., McCarroll, S., & Stevens, B.
Affiliations
  • Broad Institute (US)
  • Boston Children's Hospital (US)
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
Corresponding author
Stevens, Beth
Venue
Immunity
Publisher
openRxiv
Published
2018-08-31
Volume
50
Issue
1
Pages
253-271.e6
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2901838561
Cited by
2,225
References
83
Citations by year
2026: 257 · 2025: 312 · 2024: 304 · 2023: 343 · 2022: 351 · 2021: 308 · 2020: 218 · 2019: 123 · 2018: 4
FWCI
72.90
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Howard Hughes Medical Institute
  • Simons Foundation
  • International Rett Syndrome Foundation
  • Simons Foundation Autism Research Initiative
  • Rosetrees Trust
  • Lundbeckfonden (R182-2014-2844)
  • Stanley Center for Psychiatric Research, Broad Institute
  • Medical Research Council (MC_PC_12009)
  • National Institute of Mental Health (P50MH112491)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords
microglia, microglial heterogeneity, microglial states, brain aging, brain injury, multiple sclerosis, reactive microglia, microglial development, single-cell RNA sequencing
MeSH terms
Adaptation, Physiological, Aging, Animals, Brain, Brain Injuries, Cell Differentiation, Demyelinating Diseases, Humans, Longevity, Mice, Inbred C57BL, Multiple Sclerosis, Sequence Analysis, RNA, Microglia, Mice, Single-Cell Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review